On Monday, Adma Biologics Inc (NASDAQ: ADMA) was -4.02% drop from the session before, before settling in for the closing price of $14.66. A 52-week range for ADMA has been $13.50 – $25.67.
When this article was written, the company’s average yearly earnings per share was at 16.90%. With a float of $230.45 million, this company’s outstanding shares have now reached $239.38 million.
Considering the fact that the conglomerate employs 685 people, you should pay attention to its efficiency factor.
Adma Biologics Inc (ADMA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Adma Biologics Inc stocks. The insider ownership of Adma Biologics Inc is 3.43%, while institutional ownership is 88.99%. The most recent insider transaction that took place on Sep 15 ’25, was worth 338,730. In this transaction President and CEO of this company sold 21,000 shares at a rate of $16.13, taking the stock ownership to the 2,025,850 shares. Before that another transaction happened on Aug 15 ’25, when Company’s President and CEO sold 21,000 for $16.88, making the entire transaction worth $354,480. This insider now owns 2,031,850 shares in total.
Adma Biologics Inc (ADMA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.15 earnings per share (EPS) during the time that was better than consensus figure (set at 0.13) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.90% per share during the next fiscal year.
Adma Biologics Inc (NASDAQ: ADMA) Trading Performance Indicators
You can see what Adma Biologics Inc (ADMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.08. Likewise, its price to free cash flow for the trailing twelve months is 51.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.85, a number that is poised to hit 0.15 in the next quarter and is forecasted to reach 0.88 in one year’s time.
Technical Analysis of Adma Biologics Inc (ADMA)
Compared to the last year’s volume of 3.16 million, its volume of 3.37 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 6.83%.
During the past 100 days, Adma Biologics Inc’s (ADMA) raw stochastic average was set at 0.66%, which indicates a significant decrease from 2.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.53 in the past 14 days, which was lower than the 0.69 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.69, while its 200-day Moving Average is $18.17. Nevertheless, the first resistance level for the watch stands at $14.48 in the near term. At $14.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.13. If the price goes on to break the first support level at $13.84, it is likely to go to the next support level at $13.60. Now, if the price goes above the second support level, the third support stands at $13.19.
Adma Biologics Inc (NASDAQ: ADMA) Key Stats
There are 238,631K outstanding shares of the company, which has a market capitalization of 3.36 billion. As of now, sales total 426,450 K while income totals 197,670 K. Its latest quarter income was 121,980 K while its last quarter net income were 34,220 K.
